178 related articles for article (PubMed ID: 35992154)
1. Serum α-KL, a potential early marker of diabetes complications in youth with T1D, is regulated by miRNA 192.
Gong Z; Banchs PAP; Liu Y; Fu H; Arena VC; Forno E; Libman I; Ho J; Muzumdar R
Front Endocrinol (Lausanne); 2022; 13():937093. PubMed ID: 35992154
[TBL] [Abstract][Full Text] [Related]
2. The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy.
Lv C; Zhou YH; Wu C; Shao Y; Lu CL; Wang QY
Diabetes Metab Res Rev; 2015 Oct; 31(7):717-24. PubMed ID: 25952368
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Apoptotic, Clinical, and Laboratory Parameters in Type 1 Diabetes and Early Diabetic Nephropathy: Clustering and Potential Groups Evaluation for Additional Therapeutic Interventions.
Burlaka I
J Clin Res Pediatr Endocrinol; 2022 Aug; 14(3):313-323. PubMed ID: 35633645
[TBL] [Abstract][Full Text] [Related]
4. Urinary miRNA-377 and miRNA-216a as biomarkers of nephropathy and subclinical atherosclerotic risk in pediatric patients with type 1 diabetes.
El-Samahy MH; Adly AA; Elhenawy YI; Ismail EA; Pessar SA; Mowafy ME; Saad MS; Mohammed HH
J Diabetes Complications; 2018 Feb; 32(2):185-192. PubMed ID: 29175120
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the relationship between short-term glycemic control and netrin-1, a urinary proximal tubular injury marker in children with type 1 diabetes.
Uçaktürk SA; Mengen E; Elmaoğulları S; Yücel Ç; A Yılmaz A; Çifci A
J Pediatr Endocrinol Metab; 2019 Aug; 32(8):851-856. PubMed ID: 31219796
[TBL] [Abstract][Full Text] [Related]
6. The KL-VS polymorphism of KLOTHO gene is protective against retinopathy incidence in patients with type 1 diabetes.
Słomiński B; Ryba-Stanisławowska M; Skrzypkowska M; Myśliwska J; Myśliwiec M
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):758-763. PubMed ID: 29247834
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of nephropathy in Indian children and youth with type 1 diabetes mellitus.
Karguppikar M; Oza C; Shah N; Khadilkar V; Gondhalekar K; Khadilkar A
J Pediatr Endocrinol Metab; 2022 May; 35(5):585-592. PubMed ID: 35304981
[TBL] [Abstract][Full Text] [Related]
8. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R
PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277
[TBL] [Abstract][Full Text] [Related]
9. Atrasentan increased the expression of klotho by mediating miR-199b-5p and prevented renal tubular injury in diabetic nephropathy.
Kang WL; Xu GS
Sci Rep; 2016 Jan; 6():19979. PubMed ID: 26813039
[TBL] [Abstract][Full Text] [Related]
10. Evidence of Early Diabetic Nephropathy in Pediatric Type 1 Diabetes.
Mamilly L; Mastrandrea LD; Mosquera Vasquez C; Klamer B; Kallash M; Aldughiem A
Front Endocrinol (Lausanne); 2021; 12():669954. PubMed ID: 33995287
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with diabetic nephropathy in children, adolescents, and adults with type 1 diabetes.
Huang CY; Ting WH; Lo FS; Tsai JD; Sun FJ; Chan CI; Chiang YT; Lin CH; Cheng BW; Wu YL; Hung CM; Lee YJ
J Formos Med Assoc; 2017 Dec; 116(12):924-932. PubMed ID: 29070437
[TBL] [Abstract][Full Text] [Related]
12. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
Eissa S; Matboli M; Bekhet MM
Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-31 in Diabetic Nephropathy and its Relationship with Inflammation.
Rovira-Llopis S; Escribano-Lopez I; Diaz-Morales N; Iannantuoni F; Lopez-Domenech S; Andújar I; Jover A; Pantoja J; Pallardo LM; Bañuls C; Victor VM
Cell Physiol Biochem; 2018; 50(3):1005-1014. PubMed ID: 30355913
[TBL] [Abstract][Full Text] [Related]
14. Beta-2-microglobulin (B2M) expression in the urinary sediment correlates with clinical markers of kidney disease in patients with type 1 diabetes.
Monteiro MB; Thieme K; Santos-Bezerra DP; Queiroz MS; Woronik V; Passarelli M; Machado UF; Giannella-Neto D; Oliveira-Souza M; Corrêa-Giannella ML
Metabolism; 2016 Jun; 65(6):816-24. PubMed ID: 27173460
[TBL] [Abstract][Full Text] [Related]
15. A new potential mode of cardiorenal protection of KLOTHO gene variability in type 1 diabetic adolescents.
Słomiński B; Ryba-Stanisławowska M; Skrzypkowska M; Gabig-Cimińska M; Myśliwiec M
J Mol Med (Berl); 2020 Jul; 98(7):955-962. PubMed ID: 32435919
[TBL] [Abstract][Full Text] [Related]
16. Diabetes-associated microRNAs in pediatric patients with type 1 diabetes mellitus: a cross-sectional cohort study.
Osipova J; Fischer DC; Dangwal S; Volkmann I; Widera C; Schwarz K; Lorenzen JM; Schreiver C; Jacoby U; Heimhalt M; Thum T; Haffner D
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1661-5. PubMed ID: 24937532
[TBL] [Abstract][Full Text] [Related]
17. Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus.
Fufaa GD; Weil EJ; Nelson RG; Hanson RL; Knowler WC; Rovin BH; Wu H; Klein JB; Mifflin TE; Feldman HI; Vasan RS; Kimmel PL; Kusek JW; Mauer M;
Nephrol Dial Transplant; 2015 Apr; 30(4):599-606. PubMed ID: 25648911
[TBL] [Abstract][Full Text] [Related]
18. Association analysis of dyslipidemia-related genes in diabetic nephropathy.
McKay GJ; Savage DA; Patterson CC; Lewis G; McKnight AJ; Maxwell AP;
PLoS One; 2013; 8(3):e58472. PubMed ID: 23555584
[TBL] [Abstract][Full Text] [Related]
19. Rs12976445 Polymorphism is Associated with Risk of Diabetic Nephropathy Through Modulating Expression of MicroRNA-125 and Interleukin-6R.
Li C; Lei T
Med Sci Monit; 2015 Nov; 21():3490-7. PubMed ID: 26563755
[TBL] [Abstract][Full Text] [Related]
20. Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan.
Chien HY; Chen CY; Chiu YH; Lin YC; Li WC
Int J Med Sci; 2016; 13(6):457-65. PubMed ID: 27279796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]